Results 201 to 210 of about 1,587,143 (318)

Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case report [PDF]

, 2016
Kenya Murata, Kumiko Nakatani, Mika Yananeki, Ichiro Nakanishi, Hidefumi Ito   +4 more
openalex   +1 more source

Epidemiology of Dermatomyositis and Other Idiopathic Inflammatory Myopathies in Northern Spain. [PDF]

Biomedicines
Corrales-Selaya C, Prieto-Peña D, Martínez-López D, Benavides-Villanueva F, Blanco R.   +4 more
europepmc   +1 more source

Ultrasensitive Interferons quantification in idiopathic inflammatory myopathies serve as biomarkers of activity in dermatomyositis and anti-synthetase syndrome [PDF]

, 2020
L. Bolko, C. Anquetil, Alba Llibre, Solène Maillard, Damien Amelin, Karim Dorgham, Vincent Bondet, Oceane Landon-Cardinal, S. Toquet, K. Mariampillai, Alexandrine Mahoudeau, B. Hervier, Mathieu P. Rodero, Guy Gorochov, Darragh Duffy, Olivier Benvéniste, Yves Allenbach   +16 more
openalex   +1 more source

The Effect of Anti‐3‐Hydroxy‐3‐Methylglutaryl‐CoA Reductase (HMGCR) Human Autoantibodies on Muscle Regeneration in Mice

Muscle &Nerve, Volume 72, Issue 6, Page 1300-1308, December 2025.
ABSTRACT Introduction/Aims Anti‐3‐hydroxy‐3‐methylglutaryl‐CoA reductase (HMGCR) autoantibodies (aAbs) are pathogenic in immune‐mediated necrotizing myopathy (IMNM), partly through complement activation. C5 inhibition did not restore muscle strength in mice or patients with overt IMNM, suggesting additional pathogenic mechanisms.
Sarah Julien, Honorine Tomasevic, Thara Jaworski, Rachid Zoubairi, Jeremie Martinet, Laurent Drouot, Olivier Boyer   +6 more
wiley   +1 more source

Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights. [PDF]

Clin Rev Allergy Immunol
Wu H, Li X, Xu H, Li Z, Feng F, Zhang J, Xu Z, Ni H, Guo Y, Li Y.   +9 more
europepmc   +1 more source

Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy

Acta Physiologica, Volume 241, Issue 12, December 2025.
ABSTRACT Aim Duchenne muscular dystrophy (DMD), a rare X‐linked genetic disorder, is affecting skeletal and cardiac muscles due to the loss of the dystrophin protein. Modifier proteins, whose expression is altered in DMD patients, may influence disease progression.
Brice‐Emmanuel Guennec, Yeranuhi Hovhannisyan, Gaëlle Revet, Sila Polat, Medhi Hassani, Nathalie Mougenot, Inès Barthelemy, Stephane Blot, Caroline Cieniewski‐Bernard, Arnaud Ferry, Ekaterini Kordeli, Zhenlin Li, Onnik Agbulut   +12 more
wiley   +1 more source

HLA loci heterozygosity modulates genetic risk in idiopathic inflammatory myopathies. [PDF]

Ann Rheum Dis
Chen G, Zhu C, Chinoy H, Amos CI, Morris AP, Lamb JA, International Myositis Assessment & Clinical Studies Group (IMACS) Myositis Genetics Scientific Interest Group (MYOGEN).   +6 more
europepmc   +1 more source

Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database [PDF]

, 2020
Katinka Albrecht, Dörte Huscher, Johanna Callhoff, Jutta Richter, Tobias Alexander, Jörg Henes, A. Zink   +6 more
openalex   +1 more source

Lactylation of HMGB1 at K177 Drives Nuclear Export of TIAR to Promote Hypoxia‐Induced Stress Granule Formation

Advanced Science, Volume 12, Issue 41, November 6, 2025.
This study uncovers a novel mechanism in which p300‑catalyzed lactylation of HMGB1 triggers nuclear export of the HMGB1‐TIAR complex, driving TIAR‐dependent SGs formation in the cytoplasm. Mass spectrometry and mutagenesis reveals that K177 lactylation is essential for this export and subsequent SGs formation.
Chengyu Li, Zhaojun Liu, Linjie Zhu, Gang Wu, Chen Fu, Hongmin Li, Tong He, Ming Shen, Honglin Liu   +8 more
wiley   +1 more source

An update on the pathogenesis of idiopathic inflammatory myopathies. [PDF]

Curr Opin Rheumatol
Tiniakou E.
europepmc   +1 more source